E815
TEAS SECTION 8 & 15 RECEIVED
24/06/2026
Voltar para busca
Dado oficial do USPTO
RXE2
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RXE2
ST13
US500000088979456Classe
35, 39, 42, 44
Pedido
88979456
Registro
6235550
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
24/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 39, 42, 44
Data de depósito
07/01/2020
Data de registro
29/12/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/12/2020
Última transação
24/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
03/04/2020
Primeiro uso no comércio
03/04/2020
Código do desenho
4
Tipo de titular
03
Localização do titular
FARGO, ND, US
Examinador
NOVAKOVIC, MIROSLAV
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
RXE2 INC.
RXE2 LLC
Representantes
Joshua G. Gigger STOEL RIVES LLP
Classificação técnica
Classes Nice
Classe 35Classe 39Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Pharmaceutical and pharmacy servicesprocessing and dispensing online and telephone prescription orders for online clinical and retail pharmacies; maintaining a registry of national and international databases in the field of pharmaceuticalsmedical devicesclinical trialshealthcare; maintaining databases of pharmaciespharmacistsother healthcare professionals who can assist with the delivery of pharmaceutical services; promoting the exchange of information and resources within the pharmaceuticalmedical deviceclinical trialmedical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making physicianpharmacistother healthcare professional selection decisions; recruitment advertisement servicesposting of clinical trial notices for the purposes of providing clinical trial statusrecruiting and informing patients for participation in clinical trials for the testing of drugs and medical devices
Classe 39
Pharmacy packaging servicespackaginglabelingaligning and sorting medication by date and time into individual packages and containers for patients and healthcare professionals; delivery of goods for othersdelivery of medicationdevice and clinical supply packages and containers by date and time and category for patients and healthcare providers
Classe 42
Pharmaceutical and medical device servicesproviding pharmacist medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials for pharmaceuticalbiotechnologymedical device development and testing
Classe 44
Dispensing of medications by date and time and category for patients and healthcare providers; population health servicesgathering of global patient healthcare and behavioral data for the benefit of improving healthcare for individual patientsgroups of patientspopulations; preparation of prescriptions in pharmacies; dispensing of pharmaceuticals; providing healthcare information; medical and pharmaceutical consultation; medical and pharmaceutical counseling via online or remote communication means; medical drug monitoring and alert service for healthcare providers and patientsproviding medication therapy managementmedicinal dosageallergic sensitivityprescription safety information for medical treatment purposes; telepharmacy servicesproviding medical and pharmaceutical consultation and advice via online or remote communication means; providing information to patients in the field of administeringuse and storage of medications; and providing medical information to patients in the form of reports in the field administeringuse and storage of medications; and providing medical information to patients in the form of reports in the field of pharmaceuticals and medical devices
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29/12/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
29/12/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/11/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/11/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/11/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
03/11/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
26/10/2020
IUAF
USE AMENDMENT FILED
06/10/2020
DRRR
DIVISIONAL REQUEST RECEIVED
06/10/2020
EISU
TEAS STATEMENT OF USE RECEIVED
06/10/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/10/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2020
PUBO
PUBLISHED FOR OPPOSITION
02/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/05/2020
ALIE
ASSIGNED TO LIE
28/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/03/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
31/03/2020
GPRA
PRIORITY ACTION E-MAILED
31/03/2020
CPRA
PRIORITY ACTION WRITTEN
31/03/2020
DOCK
ASSIGNED TO EXAMINER
26/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2020
NWAP
NEW APPLICATION ENTERED
10/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RXE2 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.